Trial Profile
First in man study of GS9857 in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2015
Price :
$35
*
At a glance
- Drugs Voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors Gilead Sciences
- 07 Jul 2015 New trial record